In addition, SARS-CoV-2 infection could possibly increase future PD risk via the enhancement of neuroinflammation, immune dysregulation, oxidative stress, blood–brain barrier disruption, and ACE2 downregulation. This evidence concerns the gene ACE2 and Parkinson disease.